Generic Hospice

When hospice reverts to the lowest common denominator and leaders obsess about metrics, it's time to speak. Self-inflated leaders assume clinicians give until their backs break, given no raises for years. A clinical ladder is a rainbow’s pot of gold. Others have a sorrier job and must be motivated by money. Abysmal leaders dangle extrinsic rewards for admission, hiring and EDBITA targets. “Sign on” bonuses entice people into a poor work environment. Employees’ voice equals their raise, zero.

Wednesday, March 5, 2014

Market Responds to Gentiva's Earnings Call

StrangeTony,

I apologize for sending you so much stuff on Gentiva lately, but I appreciate your posting it on Generic Hospice. I know the for-profit business side of hospice drives you crazy, as it does most longtime hospice professionals. The picture above shows the stock market's reaction to Gentiva's earnings call. It did not inspire confidence outside the company, which remains a black hole for Senior Executive messages.

Anyway, a longtime nurse said Gentiva's stock price the last few years reminds her of her experience working for PhyCor. That ended very badly after the last round of health reform reconfigured the landscape pre-Y2K.

Here's to more posts from you about inspiring leaders at Generic, given Gentiva's are incapable of such. Our Branch Manager did extra scurrying around the last two days. Their projects feel like rearranging the deck chairs on the Titanic.

Anonymous

Generic Hospice

Wednesday, March 5, 2014

Market Responds to Gentiva's Earnings Call

No comments:

Post a Comment